Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ribera

Showing results (411-420 of 473) with videos related to

Pageof 48
Sort By:
Blood Cancer Journal|November 20, 2024
Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomabElias J Jabbour, Hagop M Kantarjian, Nicola Goekbuget, et al.
Leukemia|September 28, 2013
MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemiaM Díaz-Beyá, S Brunet, J Nomdedéu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Autologous stem-cell transplantation in patients with HIV-related lymphomaPascual Balsalobre, José L Díez-Martín, Alessandro Re, et al.
The Journal of Dermatological Treatment|September 9, 2020
Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST studyRaquel Rivera, E Vilarrasa, M Ribera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2007
Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survivalDavid Valcárcel, Rodrigo Martino, Dolores Caballero, et al.
Haematologica|January 29, 2008
High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphomaSilvia Montoto, Carol Moreno, Eva Domingo-Doménech, et al.
Bone Marrow Transplantation|July 3, 2014
Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationL Tucunduva, A Ruggeri, G Sanz, et al.
Blood|March 27, 2007
CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donorsArianne Pérez-García, Rafael De la Cámara, Jose Román-Gómez, et al.
Age and Ageing|June 1, 1999
Declaration of Yuste. European Working PartyM Lye, J L Vega Vega, J F Macías Nuñez, et al.
Haematologica|August 27, 2013
Stem cell mobilization in HIV seropositive patients with lymphomaAlessandro Re, Chiara Cattaneo, Cristina Skert, et al.
Pageof 48

Showing results (411-420 of 473) with videos related to

Sort By:
Pageof 48
Blood Cancer Journal|November 20, 2024
Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomabElias J Jabbour, Hagop M Kantarjian, Nicola Goekbuget, et al.
Leukemia|September 28, 2013
MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemiaM Díaz-Beyá, S Brunet, J Nomdedéu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Autologous stem-cell transplantation in patients with HIV-related lymphomaPascual Balsalobre, José L Díez-Martín, Alessandro Re, et al.
The Journal of Dermatological Treatment|September 9, 2020
Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST studyRaquel Rivera, E Vilarrasa, M Ribera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2007
Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survivalDavid Valcárcel, Rodrigo Martino, Dolores Caballero, et al.
Haematologica|January 29, 2008
High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphomaSilvia Montoto, Carol Moreno, Eva Domingo-Doménech, et al.
Bone Marrow Transplantation|July 3, 2014
Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationL Tucunduva, A Ruggeri, G Sanz, et al.
Blood|March 27, 2007
CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donorsArianne Pérez-García, Rafael De la Cámara, Jose Román-Gómez, et al.
Age and Ageing|June 1, 1999
Declaration of Yuste. European Working PartyM Lye, J L Vega Vega, J F Macías Nuñez, et al.
Haematologica|August 27, 2013
Stem cell mobilization in HIV seropositive patients with lymphomaAlessandro Re, Chiara Cattaneo, Cristina Skert, et al.
Pageof 48